Home/Filings/4/0001209191-22-018478
4//SEC Filing

BESHAR LUKE M 4

Accession 0001209191-22-018478

CIK 0001359931other

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 4:37 PM ET

Size

5.1 KB

Accession

0001209191-22-018478

Insider Transaction Report

Form 4
Period: 2022-03-10
Transactions
  • Purchase

    Common Stock

    2022-03-10$4.46/sh+10,000$44,555178,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.28 to $4.50, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.

Issuer

Protara Therapeutics, Inc.

CIK 0001359931

Entity typeother

Related Parties

1
  • filerCIK 0001192128

Filing Metadata

Form type
4
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:37 PM ET
Size
5.1 KB